Clinical Studies
| A Novel Treatment for Chronic-PTSD Using Post Reactivation Propranolol |
Principal investigator : Alain Brunet
Description of the study :
This study aims at testing the efficacy of a new treatment.
Financial compensations :
yes
Functionning
It consists of taking a weak dose of the medication already on the market (propranolol or placebo) and to think about the traumatic event for 10 minutes. The treatment is repeated once a week for 5 weeks (2hrs/visit) and a follow up 4 months later is required.
Eligibility criteria :
To participate in the study, subjects should:
- Be between the ages of 18 and 65
- Suffer from a post-traumatic stress disorder (PTSD)
Information :
To participate in the study, please contact :
Lening OliveraResearch coordinator
